CTOs on the Move

Enalare Therapeutics

www.enalare.com

 
Enalare Therapeutics Inc. is a privately owned clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Enalare Therapeutics raised $10M on 02/02/2021

Similar Companies

Attenua

Attenua, Inc. is a pharmaceutical company developing antitussive medications.

Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients` needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Prinston Pharm

Maker of high quality and affordable generic pharmaceutical products

BioSerenity

Solutions connectées pour le diagnostic médical

T Ray Science

Company ProfileVerisante Technology, Inc (Formerly T-Ray Science) is a medical device company committed to developing innovative systems for the early detection of cancer.